Literature DB >> 3816852

Low antithrombin III in neonatal shock: DIC or non-specific protein depletion?

B K Schmidt, T Muraji, A Zipursky.   

Abstract

Low antithrombin III (AT III) levels in shock are usually ascribed to disseminated intravascular coagulation (DIC). However, decreased activities of clotting factors and their inhibitors could reflect a generalised fall in plasma proteins rather than DIC. AT III and albumin were compared in 48 asphyxiated and non-asphyxiated newborn rabbits (pH 6.70-7.30). Both AT III and albumin were markedly decreased in the sickest animals and there was a direct linear relationship between the two proteins (P less than 0.001). Similar results were obtained in ten newborn infants suffering from shock and haemorrhagic diathesis. In all cases AT III and albumin were decreased below the normal range and significantly correlated (P less than 0.01). Our findings suggest that AT III is not a useful diagnostic marker of DIC. Further, a similar fall of clottable and non-clottable proteins in shock questions the general assumption that the ensuing coagulopathy is due to intravascular coagulation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3816852     DOI: 10.1007/bf02429051

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  21 in total

1.  Hematologic abnormalities in severe neonatal necrotizing enterocolitis.

Authors:  J J Hutter; W E Hathaway; E R Wayne
Journal:  J Pediatr       Date:  1976-06       Impact factor: 4.406

2.  Further observations on serum proteins in respiratory distress syndrome of the newborn.

Authors:  G Hardie; V C Harrison; J E Kench
Journal:  Arch Dis Child       Date:  1968-08       Impact factor: 3.791

3.  Albumin changes during clinical septic shock.

Authors:  M Deysine; N Lieblich; A H Aufses
Journal:  Surg Gynecol Obstet       Date:  1973-09

4.  Red cell volume measurements and acute blood loss in high-risk newborn infants.

Authors:  G Faxelius; J Raye; R Gutberlet; S Swanstrom; A Tsiantos; E Dolanski; M Dehan; N Dyer; D Lindstrom; A B Brill; M Stahlman
Journal:  J Pediatr       Date:  1977-02       Impact factor: 4.406

5.  Persistent antithrombin III deficiency: risk factor for thromboembolic complications in neonates small for gestational age.

Authors:  M Peters; J W ten Cate; L H Koo; C Breederveld
Journal:  J Pediatr       Date:  1984-08       Impact factor: 4.406

6.  Disseminated intravascular coagulation. Findings in 346 patients.

Authors:  J A Spero; J H Lewis; U Hasiba
Journal:  Thromb Haemost       Date:  1980-02-29       Impact factor: 5.249

7.  Low antithrombin III levels in neonates with idiopathic respiratory distress syndrome: poor prognosis.

Authors:  M Peters; J W Ten Cate; C Breederveld; R De Leeuw; J Emeis; J Koppe
Journal:  Pediatr Res       Date:  1984-03       Impact factor: 3.756

8.  Plasma elimination of antithrombin III (heparin cofactor activity) is accelerated in term newborn infants.

Authors:  B Schmidt; U Wais; W Pringsheim; W Künzer
Journal:  Eur J Pediatr       Date:  1984-02       Impact factor: 3.183

9.  Efficiency of heparin in the treatment of newborn infants with respiratory distress syndrome and disseminated intravascular coagulation.

Authors:  U Göbel; H von Voss; H Jürgens; C Petrich; R Pothmann; I Sprock; P Lemburg
Journal:  Eur J Pediatr       Date:  1980       Impact factor: 3.183

10.  Immunologic studies of antithrombin III heparin cofactor in the newborn.

Authors:  W E Hathaway; L L Neumann; C A Borden; L J Jacobson
Journal:  Thromb Haemost       Date:  1978-06-30       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.